Involvement of Crk adapter proteins in regulation of lymphoid cell functions - Immunologic Research
- ️Isakov, Noah
- ️Wed Oct 01 2003
Mayer BJ, Hamaguchi M, Hanafusa H: A novel viral oncogene with structural similarity to phospholipase C. Nature 1988;332:272–275.
Matsuda M, Tanaka S, Nagata S, Kojima A, Kurata T, Shibuya M: Two species of human CRK cDNA encode proteins with distinct biological activities. Mol Cell Biol 1992;12:3482–3489.
Reichman CT, Mayer BJ, Keshav S, Hanafusa H: The product of the cellular crk gene consists primarily of SH2 and SH3 regions. Cell Growth Differ 1992;3:451–460.
Fioretos T, Heisterkamp N, Groffen J, Benjes S, Morris C: CRK proto-oncogene maps to human chromosome band 17p13. Oncogene 1993;8:2853–2855.
Ogawa S, Toyoshima H, Kozutsumi H, Hagiwara K, Sakai R, Tanaka T, Hirano N, Mano H, Yazaki Y, Hirai H: The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells. Oncogene 1994;9:1669–1678.
ten Hoeve J, Morris C, Heisterkamp N, Groffen J: Isolation and chromosomal localization of CRKL, a human crk-like gene. Oncogene 1993;8:2469–2474.
de Jong R, Haataja L, Voncken JW, Heisterkamp N, Groffen J: Tyrosine phosphorylation of murine CrkL. Oncogene 1995;11:1469–1474.
Feller SM, Ren R, Hanafusa H, Baltimore D:SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. Trends Biochem Sci 1994:19:453–458.
Birge RB, Knudsen BS, Besser D, Hanafusa H: SH2 and SH3-containing adaptor proteins: redundant or independent mediators of intracellular signal transduction. Genes Cells 1996;1:595–613.
Kiyokawa E, Mochizuki N, Kurata T, Matsuda M: Role of Crk oncogene product in physiologic signaling. Crit Rev Oncog 1997;8:329–342.
Sattler M, Salgia R: Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells. Leukemia 1998;12:637–644.
Kolibaba KS, Bhat A, Heaney C, Oda T, Druker BJ: CRKL binding to BCR-ABL and BCR-ABL transformation. Leuk Lymphoma 1999;33:119–126.
Feller SM: Crk family adaptors-signalling complex formation and biological roles. Oncogene 2001;20:6348–6371.
Songyang Z, Shoelson SE, Chaudhuri M, et al.: SH2 domains recognize specific phosphopeptide sequences. Cell 1993;72:767–778.
Gelkop S, Babichev Y, Isakov N: T cell activation induces direct binding of the Crk adapter protein to the regulatory subunit of phosphatidy linositol 3-kinase (p85) via a complex mechanism involving the Cbl protein. J Biol Chem 2001;276:36,174–36,182.
Gelkop S, Isakov N: T cell activation stimulates theaassociation of enzymatically active tyrosine-phosphorylated ZAP-70 with the Crk adapter proteins. J Biol Chem 1999;274:21,519–21,527.
Knudsen BS, Feller SM, Hanafusa H: Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk. J Biol Chem 1994;269:32,781–32,787.
Tanaka S, Morishita T, Hashimoto Y, Hattori S, Nakamura S, Shibuya M, Matuoka K, Takenawa T, Kurata T, Nagashima K, Matsuda M: C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci USA 1994;91:3443–3447.
Knudsen BS, Zheng J, Feller SM, Mayer JP, Burrell SK, Cowburn D, Hanafusa H: Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. EMBO J 1995;14:2191–2198.
Wu X, Knudsen B, Feller SM, Zheng J, Sali A, Cowburn D, Hanafusa H, Kuriyan J: Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure 1995;3:215–226.
Smith JJ, Richardson DA, Kopf J, Yoshida M, Hollingsworth RE, Kombluth S: Apoptotic regulation by the Crk adapter protein mediated by interactions with Weel and Crml/exportin. Mol Cell Biol 2002;22:1412–1423.
Feller SM, Knudsen B, Hanafusa H: c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J 1994;13:2341–2351.
de Jong R, ten Hoeve J, Heisterkamp N, Groffen J: Tyrosine 207 in CRKL is the BCR/ABL phosphorylation site. Oncogene 1997;14:507–513.
Rosen MK, Yamazaki T, Gish GD, Kay CM, Pawson T, Kay LE: Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature 1995;374:477–479.
Anafi M, Rosen MK, Gish GD, Kay LE, Pawson T: A potential SH3 domain-binding site in the Crk SH2 domain. J Biol Chem 1996;271:21,365–21,374.
Matsuda M, Hashimoto Y, Muroya K, Hasegawa H, Kurata T, Tanaka S, Nakamura S, Hattori S: CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol Cell Biol 1994;14:5495–5500.
Sawasdikosol S, Ravichandran KS, Lee KK, Chang JH, Burakoff SJ: Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. J Biol Chem 1995;270:2893–2896.
Smit L, van der Horst G, Borst J: Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors. J Biol Chem 1996;271:8564–8569.
Zwartkruis FJ, Bos JL: Ras and Rapl: two highly related small GTPases with distinct function. Exp Cell Res 1999;253:157–165.
Bolissiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM: Maitenance of human T cell anergy: blacking of 1L-2 gene transcription by activated Rapl. Science 1997;278:124–128.
Ansen D, Kruisbeek A, Bos JL, Reedquist K: Activation of the Ras-related GTPase Rap1 by thymocyte TCR engagement and during selection. Eur J Immunol 2000;30:2832–2841.
Ishimaru S, Williams R, Clark E, Hanafusa H, Gaul U: Activation of the Drosophila C3G leads to cell fate changes and overproliferation during development, mediated by the RAS-MAPK pathway and RAP1. EMBO J 1999;18:145–155.
Zwartkruis FJ, Wolthuis RM, Nabben NM, Franke B, Bos JL: Extracellular signal-regulated activation of Rapl fails to interfere in Ras effector signalling. EMBO J 1998;17:5905–5912.
ten Hoeve J, Kaartinen V, Fioretos T, Haataja L, Voncken JW, Heisterkamp N, Groffen J: Cellular interactions of CRKL, and SH2-SH3 adaptor protein. Cancer Res 1994;54:2563–2567.
Reedquist KA, Fukazawa T, Panchamoorthy G, Langdon WY, Shoelson SE, Druker BJ, Band H: Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J Biol Chem 1996;271:8435–8442.
Arai A, Nosaka Y, Kohsaka H, Miyasaka N, Miura O: CrkL activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G. Blood 1999;93:3713–3722.
Uemura N, Salgia R, Ewaniuk DS, Little MT, Griffin JD: Involvement of the adapter protein CRKL in intergrin-mediated adhesion. Oncogene 1999;18:3343–3353.
Smith JM, Mayer BJ: Abl: mechanisms of regulation and activation. Front Biosci 2002;7:d31-d42.
ODwyer ME, Druker BJ: The role of the tyrosine kinase inhibitor ST1571 in the treatment of cancer. Curr Cancer Drug Targets 2001;1:49–57.
Shishido T, Akagi T, Chalmers A, Maeda M, Terada T, Georgescu MM, Hanafusa H: Crk family adaptor proteins trans-activate c-Abl kinase. Genes Cells 2001; 6:431–440.
Ling P, Yao Z, Meyer CF, Wang XS, Oehrl W, Feller SM, Tan TH: Interaction of hematopoietic progenitor kinase 1 with adapter proteins Crk and CrkL leads to synergistic activation of c-June N-terminal kinase. Mol Cell Biol 1999;19:1359–1368.
Ling P, Meyer CF, Redmond LP, Shui JW, Davis B, Rich RR, Hu MC, Wange RL, Tan TH: Involvement of hematopoietic progenitor kinase 1 in T cell receptor signaling. J Biol Chem 2001;276:18,908–18,914.
Gesbert F, Garbay C, Bertoglio J: Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cells. J Biol Chem 1998;273:3986–3993.
Fukazawa, T, Miyake S, Band V, Band H: Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J Biol Chem 1996;271:14,554–14,559.
Husson H, Mograbi B, Schmid-Antomarchi H, Fischer S, Rossi B: CSF-1 stimulation induces the formation of a multiprotein complex including CSF-1 receptor, c-Cbl, PI 3-kinase, Crk-II and Grb2. Oncogene 1997;14:2331–2338.
Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad KV, Griffin JD: Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-Kit, phosphatidy linositol 3-kinase, and p120Cbl. J Biol Chem 1997;272:10,248–10,253.
Chan AC, Irving BA, Fraser JD, Weiss A: The zetachain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc Natl Acad Sci USA 1991;88:9166–9170.
Katzaw S, Sutherland M, Packham G, Yi T, Weiss A: The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. J Biol Chem 1994;269:32,579–33,285.
Arpaia E, Shahar M, Dadi H, Cohen A, Roifman CM: Defective T cell receptor signaling and CD8+ thymic selection in humans lacking ZAP-70 kinase. Cell 1994;76:947–958.
Chan AC, Kadlecek TA, Elder ME, Filipovic AH, Kuo WL, Iwashima M, Parslow TG, Weiss A: ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 1994;264:1599–1601.
Elder ME, Lin D, Clever J, Chan AC, Hope TJ, Weiss A, Parslow TG: Human severe combined immunodeficiency due to a defectin ZAP-70, a T cell tyrosine kinase. Science 1994;264:1596–1599.
Xavier R, Breman T, Li Q, McCormack C, Seed B: Membrane compartmentation is required for efficient T cell activation. Immunity 1998;8:723–732.
Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML: The immunological synapse: a molecular machine controlling T cell activation. Science 1999;285:221–227.
Huby RDJ, Iwashima M, Weiss A, Ley SC: ZAP-70 protein tyrosine kinase is constitutively targeted to the T cell cortex independently of its SH2 domains. J Cell Biol 1997;137:1639–1649.
Mayer BJ, Hirai H, Sakai R: Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr Biol 1995;5:296–305.
Songyang Z, Carraway KL1, Eck MJ et al.: Catalytic specificity of protein-tyrosine kinases is critical for selective signaling. Nature 1995;373:536–539.
Isakov, N, Wange RL, Watts JD, Aebersold R, Samelson LE: Purification and characterization of human ZAP-70 proteins by tyrosine kinase from a baculovirus expression system. J Biol Chem 1996;271:15,753–15,761.
Thien CB, Langdon WY: Cbl many a daptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol 2001;2:294–307.
Liu YC, Gu H: Cbl and Cbl-bin T-cell regulation. Trends Immunol 2002;23:140–143.
Rellahan BL, Graham LJ, Stoica B, De-Bell KE, Bonvini E: Cbl-mediated regulation of T cell receptor-induced AP1 activation: implications for activation via the Ras signaling pathway. J Biol Chem 1997;272:30,806–30,811.
Ota S, Hazeki K, Rao N, Lupher ML, Jr, Andoniou CE, Druker B, Band H: The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase. J Biol Chem 2000;275:414–422.
Ota Y, Samelson LE: The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase. Science 1997;276:418–420.
Lupher ML, Jr, Rao N, Eck MJ, Band H: The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction. Immunol Today 1999;20:375–382.
Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello l, Thien CB, Langdon WY, Bowtell DD: Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol Cell Biol 1998;18:4872–4882.
van Leeuwen JE, Paik PK, Samelson LE: Activation of nuclear factor of activated T cells-(NFAT) and activating protein 1 (AP-1) by oncogenic 70Z Cbl requires and intact phosphoty rosine binding domain but not Crk(L) or p85 phosphatidy linositol 3-kinase association. J Biol Chem 1999;274:5153–5162
Zhang Z, Elly C, Altman A, Liu YC: Dual regulation of T cell receptor-mediated signaling by oncogenic Cbl mutant 70Z. J Biol Chem 1999;274:4883–4889.
Elly C, Witte S, Zhang Z, Rosnet O, Lipkowitz S, Altman A, Liu YC: Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Oncogene 1999;18:1147–1156.
Andoniou CE, Thien CB, Langdon WY: The two major sites of cbl tyrosine phosphorylation innabl-transformed cells select the crkl SH2 domain. Oncogene 1996;12:1981–1989.
Liu Y-C, Elly C, Langdon WY, Altman A: Ras-dependent, Ca2+-stimulated activation of nuclear factor of activated T cells by a constitutively active Cbl mutant in T cells. J Biol Chem 1997;272:168–173.
Hunter S, Burton EA, Wu SC, Anderson SM: Fynassociates with Cbl and phosphory lates tyrosine 731 in Cbl, a binding site for phosphatidy linositol 3-kinase. J Biol Chem 1999;274:2097–2106.
Booker GW, Gout I, Downing AK, Driscoll PC, Boyd J, Waterfield MD, Campbell ID: Solution structure and ligand-binding sites of the SH3 domain of the p85αsubunit of phosphatidy linositol 3-kinase. Cell 1993;73:813–822.
Sparks AB, Rider JE, Hoffman NG, Fowlkes DM, Quillam LA, Kay BK: Distmet ligand preferences of Srehomology 3 domains from Src, Abl, Cortactin, p53bp2, PLC gamma, Crk, and Grb2. Proc Natl Acad Sci USA 1996;93:1540–1544.
Katsuda M, Ota S, Tanimura R, Nakamura H, Matuoka K, Takenawa T, Nagashima K, Kurata T: Interaction between the amino-tenninal SH3 domain of CRK and its natural target proteins. J Biol Chem 1996;271:14,468–14,472.
Hartley D, Meisner H, Corvera S: Specific association of the beta isoform of the p8:5 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl J Biol Chem 1995;270:18,260–18,263.
Bremer B, Kadel S, Birle A, Linderkamp O: L-selectin tyrosine phosphorylates Cbl and induces association of tyrosine-phosphorylated Cbl with CrkL and Grb2. Biochem Biophys Res Commun 2001;282:41–47.
Chernock RD, Cherla RP, Ganju RK: SHP2 and cbl participate in alpha-chemokine receptor CXC R4-mediated signaling pathways. Blond 2001;97:608–615.
Uemura N, Griffin JD: The adapter protein in CrkL links Cbl to C3G after integrin ligation and enhances cell migration. J Biol Chem 1999:274:37,525–37,532.
Minegishi M, Tachibana K, Sato T, Iwata S, Nojima Y, Morimoto C: Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes. J Exp Med 1996;184:1365–1375.
Kanda H, Mimura T, Morino N, Hamasaki K, Nakamoto T, Hirai H, Morimoto C, Yazaki Y, Nojima Y: Ligation of the T cell antigen receptor induces tyrosine phosphorylation of p105CasL, a member of the p130 Cas-related docking protein family, and its subsequent binding to the Src homology 2 domain of c-Crk. Eur J Immunol 1997;27:2113–2117.
Ohashi Y, Tachibana K, Kamiguchi K, Fujita H, Morimot C: T cell receptor-mediated tyrosine phosphorylation of Cas-L, a 105-kDa Crk-associated substrate-related protein, and its association of Crk and C3G. J Biol Chem 1998;273:6446–6451.
Iwata S, Ohashi Y, Kamiguchi K, Morimoto C: Beta l-integrin-mediated cell signaling in T lymphocytes. J Dermatol Sci 2000;23:75–86.
Manie SN, Beck AR, Astier A, Law SF, Canty T, Hirai H, Druker BJ, Avraham H, Haghayeghi N, Sattler M, Salgia R, Griffin JD, Golemis EA, Freedman AS: Involvement of pl30Cas and p105HFFl, a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptoron human B cells. J Biol Chem 1997;272:4230–4236.
Petruzzelli L, Takami M, Herrera R: Adhesion through the interaction of lymphocyte function-associated antigen-1 with intracellular adhesion molecule-1 induces tyrosine phosphorylation of pl 30cas and its association with c-CrkII. J Biol Chem 1996;271:7796–7801.
Sugie K, Minami Y, Kawakami T, Uchida A: Stimulation of NK-like YT cells via leukocyte function-associated antigen (LFA)-1. Possible involvement of LFA-1-associated tyrosine kinase in signal transduction afterrecognition of NK target cells. J Immunol 1995;154:1691–1698.
Gesbert F, Guenzi C, Bertoglio J: A new tyrosine-phosphory lated 97-kDa adaptor protein mediates interleukin-2-induced association of SHP-2 with p85-phosphatidy linositol 3-kinase in human T lymphocytes. J Biol Chem 1998;273:18,273–18,281.
Carlberg K, Rohrschneider LR: Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and phosphatidy linositol 3′-kinase in myeloid cells. J Biol Chem 1997;272:15,943–15,950.
Gu H, Griffin JD, Neel BG: Characterization of two SHP-2-associated binding proteins and potential substrates in hematopoietic cells. J Biol Chem 1997;272:16,421–16,430
Craddock BL, Welham MJ: Interle ukin-3 induces association of the protein-tyrosine phosphatase SHP2 and phosphatidy linostol 3-kinase with a 100-kDa tyrosine-phosphorylated protein in hemopoietic cells. J Biol Chem 1997:272:29,281–29,289.
Evans EK, Lu W, Strum SL, Mayer BJ, Kornbluth S: Crk is required for apoptosis in Xenopus egg extracts. EMBO J 1997;16:230–241.